About Temmler Group
Temmler Group is a company based in Marburg (Germany) founded in 1917 was acquired by Aenova Group in October 2012. The company has 74 employees as of December 31, 2022. Temmler Group operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Marburg, Germany
- Employees 74 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hormosan Pharma Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
74
as on Dec 31, 2022
-
Acquired by
Aenova Group
(Oct 30, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Temmler Group
Detailed funding history for Temmler Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Temmler Group
Temmler Group has secured backing from 1 investor. Prominent investors backing the company include Aenova Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided.
|
Locked | Locked | Locked |
Investor details for Temmler Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Temmler Group
Investment portfolio details for Temmler Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Temmler Group
Detailed financials for Temmler Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Temmler Group Comparisons
Peer comparison for Temmler Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Temmler Group
Temmler Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Temmler Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Temmler Group
Complete news archive for Temmler Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Temmler Group
Temmler Group was founded in 1917.
Temmler Group is headquartered in Marburg, Germany. It is registered at Marburg, Hesse, Germany.
As of Dec 31, 2022, the latest employee count at Temmler Group is 74.
Temmler Group is a provider of contract manufacturing services for solid, semi-solid and liquid dosage forms such as gels and drops and is involved in other service segments, including the manufacture of clinical trial materials, distribution logistics and licensing. It also develops and sells its own pharmaceutical products. It has seven production sites in Germany, Ireland, Italy, and Switzerland. In October 2012, Aenova group acquired Temmler for 219M.
Temmler Group's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Temmler Group has 1 investor. Key investors include Aenova Group.